Cargando…

Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda

We previously found that age, sex, and malaria were associated with KSHV viral load in individuals from Uganda. In this study, we have evaluated factors associated with presence of EBV DNA in blood and oral fluids among the same individuals, using the same biological samples. Overall, 74% of oral fl...

Descripción completa

Detalles Bibliográficos
Autores principales: Nalwoga, Angela, Marshall, Vickie, Miley, Wendell, Labo, Nazzarena, Whitby, Denise, Newton, Robert, Rochford, Rosemary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002824/
https://www.ncbi.nlm.nih.gov/pubmed/36909626
http://dx.doi.org/10.21203/rs.3.rs-2613771/v1
_version_ 1784904468054147072
author Nalwoga, Angela
Marshall, Vickie
Miley, Wendell
Labo, Nazzarena
Whitby, Denise
Newton, Robert
Rochford, Rosemary
author_facet Nalwoga, Angela
Marshall, Vickie
Miley, Wendell
Labo, Nazzarena
Whitby, Denise
Newton, Robert
Rochford, Rosemary
author_sort Nalwoga, Angela
collection PubMed
description We previously found that age, sex, and malaria were associated with KSHV viral load in individuals from Uganda. In this study, we have evaluated factors associated with presence of EBV DNA in blood and oral fluids among the same individuals, using the same biological samples. Overall, 74% of oral fluids samples and 46% of PBMCs had detectable EBV, compared to 24% and 11% for KSHV respectively Individuals with EBV in PBMCs were more likely to have KSHV in PBMCs (P=0.016). The peak age for detection of EBV in oral fluids was 3–5 years while that of KSHV was 6–12 years. In PBMCs, the peak age for detection of EBV was 66+ years and KSHV was 3–5 years. Individuals with malaria had higher levels of EBV in PBMCs compared to malaria-negative individuals (P=0.002). In summary, our results show that younger age and malaria are associated with higher levels of EBV and KSHV in PBMCs suggesting malaria impacts immunity to EBV and KSHV.
format Online
Article
Text
id pubmed-10002824
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-100028242023-03-11 Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda Nalwoga, Angela Marshall, Vickie Miley, Wendell Labo, Nazzarena Whitby, Denise Newton, Robert Rochford, Rosemary Res Sq Article We previously found that age, sex, and malaria were associated with KSHV viral load in individuals from Uganda. In this study, we have evaluated factors associated with presence of EBV DNA in blood and oral fluids among the same individuals, using the same biological samples. Overall, 74% of oral fluids samples and 46% of PBMCs had detectable EBV, compared to 24% and 11% for KSHV respectively Individuals with EBV in PBMCs were more likely to have KSHV in PBMCs (P=0.016). The peak age for detection of EBV in oral fluids was 3–5 years while that of KSHV was 6–12 years. In PBMCs, the peak age for detection of EBV was 66+ years and KSHV was 3–5 years. Individuals with malaria had higher levels of EBV in PBMCs compared to malaria-negative individuals (P=0.002). In summary, our results show that younger age and malaria are associated with higher levels of EBV and KSHV in PBMCs suggesting malaria impacts immunity to EBV and KSHV. American Journal Experts 2023-03-02 /pmc/articles/PMC10002824/ /pubmed/36909626 http://dx.doi.org/10.21203/rs.3.rs-2613771/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Article
Nalwoga, Angela
Marshall, Vickie
Miley, Wendell
Labo, Nazzarena
Whitby, Denise
Newton, Robert
Rochford, Rosemary
Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
title Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
title_full Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
title_fullStr Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
title_full_unstemmed Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
title_short Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
title_sort comparison of epstein-barr virus and kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of hiv-negative individuals aged 3 to 89 years from uganda
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002824/
https://www.ncbi.nlm.nih.gov/pubmed/36909626
http://dx.doi.org/10.21203/rs.3.rs-2613771/v1
work_keys_str_mv AT nalwogaangela comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda
AT marshallvickie comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda
AT mileywendell comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda
AT labonazzarena comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda
AT whitbydenise comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda
AT newtonrobert comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda
AT rochfordrosemary comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda